A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody-Reference-Cited by-同舟云学术

A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody

Published:2023-09 Issue:5 Volume:50 Page:446-458
ISSN:1467-2987
Container-title:Veterinary Anaesthesia and Analgesia
language:en
Short-container-title:Veterinary Anaesthesia and Analgesia

Author:

Michels Gina M.,Honsberger Nicole A.,Walters Rodney R.,Kira S. Tena Jezaniah,Cleaver Dawn M.

Funder

Zoetis

Zoetis Inc

Publisher

Elsevier BV

Subject

General Veterinary

Reference46 articles.

1. Targeting nerve growth factor (NGF) for pain management: what does the future hold for NGF-antagonists?;Bannwarth;Drugs,2014

2. Strategies and challenges for the next generation of therapeutic antibodies;Beck;Nat Rev Immunol,2010

3. The canine brief pain inventory;Brown,2017

4. Power of treatment success definitions when the Canine Brief Pain Inventory is used to evaluate carprofen treatment for the control of pain and inflammation in dogs with osteoarthritis;Brown;Am J Vet Res,2013

5. Non-steroidal anti-inflammatory drugs in the pharmacological management of osteoarthritis in the very old: prescribe or proscribe?;Cadet;Ther Adv Musculoskelet Dis,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Client-based evaluation of the effects of localized vibration therapy on pain and mobility scores in dogs with radiographic bilateral hip dysplasia;Frontiers in Veterinary Science;2024-08-21

2. Re: Laboratory Safety Evaluation of Bedinvetmab, a Canine Anti-Nerve Growth Factor Monoclonal Antibody, in Dogs. The Veterinary Journal 106175, Issn 1090-0233;2024